1002 GMT - Royal Philips's first-quarter results are expected to show incremental tariff headwinds, RBC Capital Markets analysts say in a research note. The Dutch medical-technology company is due to post the results next month, and RBC expects sales growth and profitability to be slightly below consensus estimates. The analysts forecast Philips's like-for-like sales growth excluding currency changes at 3.1% against consensus estimates of 3.3%, and an adjusted Ebita margin of 8.2% compared with consensus expectations of 8.3%. Tariff challenges, more normalized growth for sales of personal-health products in China and a longer lag to convert diagnosis-and-treatment orders to revenue partly explain this, the analysts add. Philips shares rise 4.3%. (adria.calatayud@wsj.com)
(END) Dow Jones Newswires
April 08, 2026 06:02 ET (10:02 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments